Call Options

26 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$27.7 - $31.39 $129 Million - $146 Million
-4,646,900 Reduced 94.14%
289,500 $8.38 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $125 Million - $146 Million
4,936,400 New
4,936,400 $138 Million
Q4 2023

Feb 15, 2024

BUY
$26.13 - $33.94 $13.3 Million - $17.3 Million
510,000 Added 182.14%
790,000 $22.7 Million
Q3 2023

Nov 07, 2023

SELL
$32.09 - $37.51 $10.6 Million - $12.4 Million
-331,400 Reduced 54.2%
280,000 $9.29 Million
Q2 2023

Aug 03, 2023

BUY
$36.12 - $41.79 $1.88 Million - $2.17 Million
52,000 Added 9.3%
611,400 $22.4 Million
Q1 2023

May 04, 2023

BUY
$39.39 - $51.28 $547,521 - $712,792
13,900 Added 2.55%
559,400 $22.8 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $22.8 Million - $29.7 Million
545,500 New
545,500 $28 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $5.37 Million - $6.37 Million
115,400 Added 178.64%
180,000 $9.44 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $9.9 Million - $14.7 Million
-239,600 Reduced 78.76%
64,600 $3.82 Million
Q3 2021

Nov 09, 2021

SELL
$39.25 - $50.42 $13.5 Million - $17.4 Million
-345,200 Reduced 53.16%
304,200 $13.1 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $1.01 Million - $1.14 Million
28,000 Added 4.51%
649,400 $25.4 Million
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $401,880 - $453,240
-12,000 Reduced 1.89%
621,400 $22.5 Million
Q4 2020

Feb 11, 2021

SELL
$33.47 - $42.56 $394,946 - $502,208
-11,800 Reduced 1.83%
633,400 $23.3 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $10.5 Million - $12.3 Million
331,500 Added 105.67%
645,200 $23.7 Million
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $15 Million - $18.1 Million
-496,500 Reduced 61.28%
313,700 $10.3 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $710,889 - $1.02 Million
-26,300 Reduced 3.14%
810,200 $26.4 Million
Q4 2019

Feb 10, 2020

SELL
$32.92 - $37.36 $888,840 - $1.01 Million
-27,000 Reduced 3.13%
836,500 $32.8 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $4.72 Million - $6.12 Million
-145,200 Reduced 14.39%
863,500 $31 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $9.33 Million - $10.5 Million
252,400 Added 33.37%
1,008,700 $43.7 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $1.61 Million - $1.77 Million
43,000 Added 6.03%
756,300 $32.1 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $4.97 Million - $5.67 Million
129,200 Added 22.12%
713,300 $31.1 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $2.16 Million - $2.62 Million
-62,600 Reduced 9.68%
584,100 $25.7 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $9.76 Million - $10.4 Million
-295,800 Reduced 31.38%
646,700 $23.5 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $14.9 Million - $17.2 Million
465,900 Added 97.75%
942,500 $33.4 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $5.99 Million - $6.36 Million
180,200 Added 60.8%
476,600 $17.3 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $9.19 Million - $10.1 Million
296,400
296,400 $10.6 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.